151 related articles for article (PubMed ID: 25596089)
1. Insulin-like growth factor 1 promotes growth of gastric cancer by inhibiting foxo1 nuclear retention.
Li S; Lei X; Zhang J; Yang H; Liu J; Xu C
Tumour Biol; 2015 Jun; 36(6):4519-23. PubMed ID: 25596089
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.
Pöllänen E; Ronkainen PH; Horttanainen M; Takala T; Puolakka J; Suominen H; Sipilä S; Kovanen V
Growth Horm IGF Res; 2010 Oct; 20(5):372-9. PubMed ID: 20724185
[TBL] [Abstract][Full Text] [Related]
3. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
[TBL] [Abstract][Full Text] [Related]
4. Insulin-Like Growth Factor 1 Activates PI3k/Akt Signaling to Antagonize Lumbar Disc Degeneration.
Liu Z; Zhou K; Fu W; Zhang H
Cell Physiol Biochem; 2015; 37(1):225-32. PubMed ID: 26302720
[TBL] [Abstract][Full Text] [Related]
5. PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.
Akundi RS; Zhi L; Büeler H
Neurobiol Dis; 2012 Jan; 45(1):469-78. PubMed ID: 21945539
[TBL] [Abstract][Full Text] [Related]
6. Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro.
Mirdamadi Y; Thielitz A; Wiede A; Goihl A; Papakonstantinou E; Hartig R; Zouboulis CC; Reinhold D; Simeoni L; Bommhardt U; Quist S; Gollnick H
Mol Cell Endocrinol; 2015 Nov; 415():32-44. PubMed ID: 26257240
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways.
Wang H; Su X; Fang J; Xin X; Zhao X; Gaur U; Wen Q; Xu J; Little PJ; Zheng W
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213025
[TBL] [Abstract][Full Text] [Related]
8. GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4.
Huo X; Liu S; Shao T; Hua H; Kong Q; Wang J; Luo T; Jiang Y
J Biol Chem; 2014 Sep; 289(36):24759-70. PubMed ID: 25053419
[TBL] [Abstract][Full Text] [Related]
9. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
[TBL] [Abstract][Full Text] [Related]
10. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
11. The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5-fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway.
Han A; Liu T; Du P; Wang M; Liu J; Chen L
Mol Carcinog; 2024 Apr; 63(4):688-700. PubMed ID: 38224261
[TBL] [Abstract][Full Text] [Related]
12. Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation.
Ganguly S; Basu B; Shome S; Jadhav T; Roy S; Majumdar J; Dasgupta PS; Basu S
Am J Pathol; 2010 Dec; 177(6):2701-7. PubMed ID: 21075859
[TBL] [Abstract][Full Text] [Related]
13. The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells.
Bumke-Vogt C; Osterhoff MA; Borchert A; Guzman-Perez V; Sarem Z; Birkenfeld AL; Bähr V; Pfeiffer AF
PLoS One; 2014; 9(8):e104321. PubMed ID: 25136826
[TBL] [Abstract][Full Text] [Related]
14. PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle.
Southgate RJ; Bruce CR; Carey AL; Steinberg GR; Walder K; Monks R; Watt MJ; Hawley JA; Birnbaum MJ; Febbraio MA
FASEB J; 2005 Dec; 19(14):2072-4. PubMed ID: 16203862
[TBL] [Abstract][Full Text] [Related]
15. Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.
Ko YS; Cho SJ; Park J; Kim Y; Choi YJ; Pyo JS; Jang BG; Park JW; Kim WH; Lee BL
Br J Cancer; 2015 Oct; 113(8):1186-96. PubMed ID: 26448177
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses.
Qi L; Toyoda H; Shankar V; Sakurai N; Amano K; Kihira K; Iwasa T; Deguchi T; Hori H; Azuma E; Gabazza EC; Komada Y
Cancer Sci; 2013 Sep; 104(9):1162-71. PubMed ID: 23710710
[TBL] [Abstract][Full Text] [Related]
17. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components.
Wu AL; Kim JH; Zhang C; Unterman TG; Chen J
Endocrinology; 2008 Mar; 149(3):1407-14. PubMed ID: 18079193
[TBL] [Abstract][Full Text] [Related]
18. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
19. GRP78/BiP is a novel downstream target of IGF-1 receptor mediated signaling.
Pfaffenbach KT; Pong M; Morgan TE; Wang H; Ott K; Zhou B; Longo VD; Lee AS
J Cell Physiol; 2012 Dec; 227(12):3803-11. PubMed ID: 22422508
[TBL] [Abstract][Full Text] [Related]
20. Insulin attenuates the insulin-like growth factor-I (IGF-I)-Akt pathway, not IGF-I-extracellularly regulated kinase pathway, in luteinized granulosa cells with an increase in PTEN.
Iwase A; Goto M; Harata T; Takigawa S; Nakahara T; Suzuki K; Manabe S; Kikkawa F
J Clin Endocrinol Metab; 2009 Jun; 94(6):2184-91. PubMed ID: 19318457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]